Many questions remain unanswered about neurosarcoidosis, and substantial investments in future research are needed to improve our understanding of the disease, and to expand our ability to treat it.
Our team is active in clinical research on neurosarcoidosis, especially studies focused on improving the diagnosis and evaluating the effects of treatment. The team regularly participates in national conferences to discuss our research findings and we are engaged with other major academic medical centers to advance research priorities for neurosarcoidosis.
Some of the studies published in recent years by members of the team are noted below.
2023
- Tumefactive Brain Parenchymal Neurosarcoidosis (Journal of Neurology)
- Hydrocephalus in Neurosarcoidosis: Clinical Course, Radiographic Accompaniments, and Experience with Shunting (Multiple Sclerosis & Related Disorders)
2022
- Neurosarcoidosis of the Cauda Equina: Clinical Course, Radiographic and Electrodiagnostic Findings, Response to Treatment, and Outcomes (Neurology: Neuroimmunology and Neuroinflammation)
- Facial Nerve Palsy in Neurosarcoidosis: Clinical Course, Neuroinflammatory Accompaniments, Ancillary Investigations, and Response to Treatment (Journal of Neurology)
- Pachymeningitis in Biopsy-proven Sarcoidosis: Clinical Course, Radiographic Findings, Response to Treatment, and Long-term Outcomes (Neurology: Neuroimmunology and Neuroinflammation)
- Ischemic Stroke in Neurosarcoidosis: a Retrospective Cohort Analysis (Multiple Sclerosis & Related Disorders)
2021
- Adalimumab for CNS Sarcoidosis: Single Center Experience and Literature Review (Journal of Neurology)